All diabetes articles – Page 3
-
Business
US turnaround on Avandia restrictions
Researchers accuse regulator of face-saving U-turn over diabetes medication safety
-
NewsIndian U-turn on diabetes drug ban
Suspension of cheap and popular medicine reversed but will now come with new safety warnings
-
Business
Judge reverses jury decision over $6.5m Takeda payout
Not enough evidence to link diabetes drug to bladder cancer, the company claims
-
Business
Generic Actos approved
Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets
-
Business
BMS and AstraZeneca buy Amylin for $7bn
Two pharma giants have teamed up to buy US biotech Amylin, responsible for the Byetta and Bydureon anti-diabetes brands
- Previous Page
- Page1
- Page2
- Page3
- Next Page